Topical medications remain the cornerstone ... have been used in ophthalmic preparations. The repetitious use of ophthalmic medicines, which is often necessary to treat diseases such as glaucoma ...

Advanced Phase 3 CHAPERONE study of MicroPine as a treatment of pediatric progressive myopia with preparations for interim analysis this ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. I'm a Fitness & Nutrition ...

Abstract: Systems, eye-mountable devices, and methods that facilitate chronotherapeutic treatment of primary open-angle ...

In June 2024, a canalicular gel device (Lacrifill, Nordic Pharma) was introduced to the US market, and a recent study has ...

You may have seen advertisements claiming to eliminate the need for eyeglasses through vision therapy or vision training – ...

NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ...

Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF inhibitor bevacizumab to be cleared for use by the NHS in England and Wales for treating wet age-related macular ...

Refers to the latest 2 years of stltoday.com stories. Cancel anytime. On this episode of the Eye on the Tigers Podcast, Eli ...

A new study published in Asia-Pacific Journal of Ophthalmology has explored the relationship between short term atropine use ...